when were glp 1 drugs approved GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1R Agonists for Weight Loss
Description
It activates receptors in the pancreas for blood sugar management by regulating insulin and inhibiting glucagon release
Gonzalez-Campoy JM, St Jeor ST, Castorino K, Ebrahim A, Hurley D, Jovanovic L, et al
The second study looked at 635 patients with type 2 diabetes who were also overweight or obese
The search was limited to outcome trials evaluating the efficacy of DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors on cardiovascular, heart failure or renal outcomes in adult patients with or without type 2 diabetes
GLP-1RAs may be viable for overweight or obese T1DM patients struggling to reach their blood sugar targets
